UT MD Anderson shares latest research breakthroughs
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Oct-2026 19:16 ET (19-Oct-2026 23:16 GMT/UTC)
First-in-class targeted therapy shows promise against hard-to-treat cancers
Tile-based radiation therapy dramatically reduced recurrence of brain metastases
Targeting individual metastases in oligometastatic breast cancer did not improve survival
Personalized guidance boosts family genetic testing for hereditary cancers
AI tool uncovers signals that either attract immune cells to tumors or keep them out
Mass General Brigham and Harvard Medical School researchers analyzed more than 270 million queries from nearly 1 million clinicians using the AI platform OpenEvidence, finding widespread adoption and showing that clinicians often use AI to support treatment decisions, rather than diagnosis, and that clinicians frequently sought information beyond their own specialty.
ExpressPath, a new licensing model for Harvard engineering, medical device, and software technologies, is helping academic innovators turn promising ideas into real-world products faster and more efficiently.